Theradiag S.A. / Fundamentals

    Income statement

    Net revenue
    €13.51M
    Cost of goods sold
    €7.24M
    Gross profit
    €6.26M
    SG&A expenses
    €4.60M
    R&D expenses
    €0.00
    EBITDA
    €1.16M
    D&A
    €245.63K
    EBIT
    €686.09K
    Interest expenses
    €82.30K
    EBT
    €206.22K
    Tax expenses
    €215.70K
    Net income
    €421.92K

    Cash flow statement

    Net deferred tax
    €0.00
    Non-cash items
    -€421.92K
    Changes in working capital
    €0.00
    Operating cash flow
    €0.00
    Capex
    €0.00
    Other investing cash flow
    €0.00
    Net investing cash flow
    €0.00
    Total cash dividends paid
    €0.00
    Issuance of common stock
    €0.00
    Debt repayment
    €0.00
    Other financing cash flow
    €0.00
    Net financing cash flow
    €0.00
    Foreign exchange effects
    €0.00
    Net change in cash
    €0.00
    Cash at end of period
    €0.00
    Free cash flow
    €0.00

    Balance sheet

    Cash and cash equivalents
    €5.67M
    Cash and short-term investments
    €5.67M
    Total receivables
    €2.60M
    Inventory
    €2.35M
    Other current assets
    €2.00
    Total current assets
    €10.63M
    Property, plant & equipment
    €236.52K
    Goodwill
    €0.00
    Intangible assets
    €3.13M
    Long-term investments
    €0.00
    Other non-current assets
    €473.57K
    Total non-current assets
    €3.84M
    Total assets
    €14.47M
    Accounts payable
    €1.49M
    Short-term debt
    €0.00
    Other current liabilities
    €85.08K
    Total current liabilities
    €2.47M
    Long-term debt
    €1.59M
    Deferred tax liabilities
    €0.00
    Other non-current liabilities
    €0.00
    Total non-current liabilities
    €2.70M
    Total liabilities
    €5.17M
    Common stock
    €13.28M
    Retained earnings
    -€4.04M
    Other equity
    €1.00
    Total equity
    €9.30M
    Total liabilities and shareholders' equity
    €14.47M

    Company information

    Market capitalization
    €17.29M
    Employees
    60
    Enterprise Value
    €12.74M

    Company ratios

    Gross margin
    46.4% Better than peer group: 37.8%
    EBITDA margin
    8.6% Much better than peer group: -62.8%
    EBIT margin
    5.1% Much better than peer group: -72.2%
    EBT margin
    1.5% Much better than peer group: -80.1%
    Net margin
    3.1% Much better than peer group: -81.4%
    ROE
    4.5% Much better than peer group: -61.7%
    ROA
    2.9% Much better than peer group: -36.3%
    Asset turnover
    93.3% Better than peer group: 85.5%
    FCF margin
    0.0%
    FCF yield
    0.0%
    Efficiency ratio
    91.4%
    Net sales per employee
    €225.10K
    Net income per employee
    €7.03K

    Notifications